Pharmacology News

Healio spoke with Grace Cheng, PharmD, APh, BCACP, BCGP, about what types of medication may have lowered efficacy among patients with obesity, how to inform patients about these medications and more.

An interrupted time-series analysis showed little change in the rate of abortion-related adverse events and complications in Ontario, Canada, before and after the country lifted prescribing restrictions on mifepristone.

Adults with osteoarthritis who exercised daily reduced their pain, produced anti-inflammatory cytokines and increased their levels of endocannabinoids, according to findings published in Gut Microbes.

In a cohort of noncritically ill patients with COVID-19, the addition of a P2Y12 inhibitor to anticoagulation did not extend survival or lessen disease severity, according to results of the ACTIV-4a trial.

Biden administration officials recently discussed several initiatives within a multi-pronged, multi-agency collaboration that they said are needed to address the overdose epidemic.

Among patients with predisposing factors for HF, aspirin use was associated with a 26% increased risk for HF development, researchers reported in ESC Heart Failure.

Nearly one in five U.S. adults with hypertension said they took a medication that may worsen the condition, according to a cross-sectional analysis of National Health and Nutrition Examination Survey data.

The offspring of mothers who received 17-hydroxyprogesterone caproate during pregnancy may face nearly double the risk for cancer compared with those who were not exposed, according to a recent study.

Patients from community mental health centers who expressed concerns about developing drug-induced movement disorders tended to report worse health and daily functioning, according to study results presented at NEI Congress.

A lower dose of oral amoxicillin was noninferior to a higher dose in children with community-acquired pneumonia who were discharged from an ED or hospital ward, according to results of a 2x2 factorial, randomized clinical trial in JAMA.